Wedbush Securities Inc Kala Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

$2.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$0.3 - $1.31 $210 - $917	-700 Reduced 3.34%	20,286 $6,000
Q1 2022 Apr 19, 2022	SELL	$0.61 - $1.84 $4,965 - $14,977	-8,140 Reduced 27.95%	20,986 $28,000
Q4 2021 Jan 13, 2022	SELL	$1.16 - $2.74 $2,610 - $6,165	-2,250 Reduced 7.17%	29,126 $35,000
Q3 2021 Oct 08, 2021	SELL	$2.62 - $5.43 $61,570 - $127,605	-23,500 Reduced 42.82%	31,376 $82,000
Q2 2021 Jul 27, 2021	BUY	$5.06 - $8.15 $156 - $252	31 Added 0.06%	54,876 $290,000
Q1 2021 Apr 26, 2021	BUY	$6.24 - $9.58 $201,333 - $309,098	32,265 Added 142.89%	54,845 $369,000
Q4 2020 Feb 16, 2021	SELL	$6.28 - $8.79 $959,113 - $1.34 Million	-152,725 Reduced 87.12%	22,580 $153,000
Q3 2020 Oct 20, 2020	BUY	$7.5 - $11.11 $508,282 - $752,935	67,771 Added 63.02%	175,305 $1.32 Million
Q2 2020 Jul 16, 2020	SELL	$8.33 - $13.79 $55,969 - $92,655	-6,719 Reduced 5.88%	107,534 $1.13 Million
Q1 2020 Apr 17, 2020	SELL	$3.83 - $8.79 $161,936 - $371,649	-42,281 Reduced 27.01%	114,253 $1 Million
Q4 2019 Jan 16, 2020	BUY	$3.36 - $4.81 $226,158 - $323,756	67,309 Added 75.44%	156,534 $578,000
Q3 2019 Oct 17, 2019	BUY	$3.57 - $6.58 $197,813 - $364,597	55,410 Added 163.86%	89,225 $340,000
Q2 2019 Aug 01, 2019	SELL	$4.93 - $8.8 $410,738 - $733,163	-83,314 Reduced 71.13%	33,815 $216,000
Q1 2019 Apr 17, 2019	SELL	$5.19 - $8.97 $17,542 - $30,318	-3,380 Reduced 2.8%	117,129 $969,000
Q4 2018 Jan 31, 2019	BUY	$4.29 - $9.94 $20,120 - $46,618	4,690 Added 4.05%	120,509 $589,000
Q3 2018 Nov 13, 2018	BUY	$9.54 - $13.87 $566,666 - $823,864	59,399 Added 105.28%	115,819 $1.14 Million
Q2 2018 Aug 03, 2018	BUY	$13.3 - $17.49 $337,155 - $443,371	25,350 Added 81.59%	56,420 $775,000
Q1 2018 May 01, 2018	BUY	$12.26 - $18.98 $36,780 - $56,940	3,000 Added 10.69%	31,070 $492,000
Q4 2017 Feb 09, 2018	BUY	$13.68 - $23.17 $383,997 - $650,381	28,070	28,070 $519,000

Others Institutions Holding KALA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Parallel Advisors, LLC

1
Shares

$5
0.0% of portfolio

View Full List

About Kala Pharmaceuticals, Inc.

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

More about KALA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Account